AA
Aftab Ahmad
About Aftab Ahmad
Data last updated:
Aftab Ahmad is a Director at Sun Rays Lifesciences Private Limited (since 2011). The companies operate in Pharma. Sun Rays Lifesciences Private Limited reported revenue of ₹61.9 Lakh (FY 2024). Earlier, Aftab Ahmad was a Director at Sunzone Lifesciences Private Limited (from 2015).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sun Rays Lifesciences Private Limited U85191UP2011PTC046770 | Director | 28 Sep 2011 | 2011 | ₹61.9 Lakh (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Sunzone Lifesciences Private Limited U24233UP2015PTC074768 | Director | 01 Dec 2015 | 2015 | ₹8.7 Lakh (FY 2020) | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Aftab Ahmad
| Name | DIN | Company | Designation |
|---|---|---|---|
| Jay Prakash Agrawal | 06531753 | Sun Rays Lifesciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Aftab Ahmad
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aftab Ahmad
Aftab Ahmad currently holds 1 directorship: Sun Rays Lifesciences Private Limited (Director, since 28 Sep 2011, revenue ₹61.9 Lakh (FY 2024)).
Aftab Ahmad was first appointed on 28 Sep 2011 as Director at Sun Rays Lifesciences Private Limited. The most recent appointment on record is 01 Dec 2015 at Sunzone Lifesciences Private Limited.
Aftab Ahmad held 1 earlier board appointment: Sunzone Lifesciences Private Limited (Director, from 01 Dec 2015).
The current boards of Aftab Ahmad's companies include Jay Prakash Agrawal (Sun Rays Lifesciences Private Limited).